×
About 2,823 results

ALLMedicine™ Cardiovascular Risk Management Center

Research & Reviews  283 results

Obesity and cardiovascular risk management is a critical way to reduce healthcare resou...
https://doi.org/10.1177/2047487320929248
European Journal of Preventive Cardiology; Chen L, Hao G

Feb 21st, 2021 - Obesity and cardiovascular risk management is a critical way to reduce healthcare resource pressure.|2021|Chen L,Hao G,|

National digestive disease specialists survey on cardiovascular risk management in non-...
https://doi.org/10.1111/liv.14807
Liver International : Official Journal of the Internation... Iruzubieta P, Arias-Loste MT et. al.

Feb 2nd, 2021 - Cardiovascular disease (CVD) is the main cause of mortality among non-alcoholic fatty liver disease (NAFLD) patients. The aim was to explore the level of knowledge and clinical management of cardiovascular risk (CVR) in NAFLD patients by Digestive...

Can cardiovascular risk management be improved by shared care with general practice to ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499986
BMC Geriatrics; Davison WJ, Myint PK et. al.

Sep 18th, 2020 - Cognitive impairment and dementia following cerebrovascular disease are increasingly common in the UK. One potential strategy to prevent post-stroke cognitive decline is multimodal vascular risk factor management. However, its efficacy remains unc...

Effectiveness of a prevention program in the incidence of cardiovascular outcomes in a ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500541
BMC Public Health; Miranda-Machado P, Salcedo-Mejía F et. al.

Sep 18th, 2020 - Cardiovascular diseases (CVDs) and diabetes mellitus (DM) are among the leading cause of morbidity and mortality in low-and-middle-income countries (LMICs) but evidence in these contexts regarding the effectiveness of primary prevention interventi...

Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women an...
https://doi.org/10.1097/SLA.0000000000004182
Annals of Surgery; Bulder RMA, Talvitie M et. al.

Jul 13th, 2020 - To evaluate the impact of changes in elective Abdominal Aortic Aneurysm (AAA) management on life-expectancy of AAA patients. Over the past decades AAA repair underwent substantial changes, that is, the introduction of EVAR and implementation of in...

see more →

Guidelines  5 results

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduct...
http://www.onlinejacc.org/content/early/2018/11/23/j.jacc.2018.09.020

Nov 25th, 2018 - Despite major therapeutic advances leading to improved outcomes over the past 2 decades, cardiovascular (CV) disease remains the leading cause of morbidity and mortality in patients with type 2 diabetes (T2D) (1). Over that time, the prevalence of.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of ...
http://www.onlinejacc.org/content/early/2018/11/02/j.jacc.2018.11.003
Grundy, S.,et al

Nov 9th, 2018 - The recommendations listed in the present guideline are, whenever possible, evidence based. An initial extensive evidence review, which included literature derived from research involving human subjects, published in English, and indexed in MEDLIN.

Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018
http://care.diabetesjournals.org/lookup/doi/10.2337/dc18-S009
American Diabetes Association

Dec 31st, 2017 - Atherosclerotic cardiovascular disease (ASCVD)—defined as coronary heart disease, cerebrovascular disease, or peripheral arterial disease presumed to be of atherosclerotic origin—is the leading cause of morbidity and mortality for individuals with.

2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Sta...
http://www.onlinejacc.org/content/early/2017/08/30/j.jacc.2017.07.745
Lloyd-Jones, D.,et al.

Sep 4th, 2017 - In 2016, the American College of Cardiology published the first expert consensus decision pathway (ECDP) on the role of non-statin therapies for low-density lipoprotein (LDL)–cholesterol lowering in the management of atherosclerotic cardiovascular.

EULAR evidence-based recommendations for cardiovascular risk management in patients wit...
https://doi.org/10.1136/ard.2009.113696
Annals of the Rheumatic Diseases; Peters MJ, Symmons DP et. al.

Sep 23rd, 2009 - To develop evidence-based EULAR recommendations for cardiovascular (CV) risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). A multidisciplinary expert committee was convened as a t...

see more →

Drugs  1,099 results see all →

Clinicaltrials.gov  1,411 results

Prazosin hydrochloride - prazosin hydrochloride capsule-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=55e74841-23f1-4cfb-97b2-8bd2d2329b0e

Feb 28th, 2021 - Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These ben...

Lisinopril and hydrochlorothiazide - lisinopril and hydrochlorothiazide tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd62e287-b648-459a-9414-621686c6b607

Feb 28th, 2021 - Lisinopril and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarct...

Atenolol - atenolol tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=991dd367-856a-411b-b80e-5b37b0536e7b

Feb 28th, 2021 - Atenolol tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been...

Lisinopril and hydrochlorothiazide - lisinopril and hydrochlorothiazide tablet-NuCare Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4925a3ad-63bd-108a-e054-00144ff8d46c

Feb 22nd, 2021 - Lisinopril and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarct...

Obesity and cardiovascular risk management is a critical way to reduce healthcare resou...
https://doi.org/10.1177/2047487320929248
European Journal of Preventive Cardiology; Chen L, Hao G

Feb 21st, 2021 - Obesity and cardiovascular risk management is a critical way to reduce healthcare resource pressure.|2021|Chen L,Hao G,|

see more →

News  25 results

Chronic, Preventive Care Fell as Telemedicine Soared During COVID
https://www.medscape.com/viewarticle/938615

Oct 4th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. As the COVID-19 pandemic drove down the number of primary care visits and altered the method — moving many to telehealth appointments instead of ...

Treatment Tips as COVID-19 Complicates CVD Management in Diabetes
https://www.staging.medscape.com/viewarticle/930994

May 21st, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape' Coronavirus Resource Center. A new article outlines the many ways in which the COVID-19 pandemic necessitates new considerations beyond traditional cardiovascular risk manageme...

Treatment Tips as COVID-19 Complicates CVD Management in Diabetes
https://www.medscape.com/viewarticle/930994

May 21st, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape' Coronavirus Resource Center. A new article outlines the many ways in which the COVID-19 pandemic necessitates new considerations beyond traditional cardiovascular risk manageme...

Cardiovascular risk management supported for type 2 diabetes
https://www.mdedge.com/neurology/article/172877/mixed-topics/cardiovascular-risk-management-supported-type-2-diabetes

Aug 17th, 2018 - Two studies published in the New England Journal of Medicine support managing cardiovascular risk in patients with type 2 diabetes. Also today, spontaneous intracranial hypotension is a triple misnomer, prolonged antimalarial therapy is linked to.

Studies support cardiovascular risk management in T2DM
https://www.mdedge.com/familymedicine/article/172698/diabetes/studies-support-cardiovascular-risk-management-t2dm/page/0/1
Clinical Endocrinology News;

Aug 15th, 2018 - The second study, which included 271,174 patients with T2DM from the Swedish National Diabetes Register and 1,355,870 controls, examined five risk factors: elevated glycated hemoglobin level, elevated low-density lipoprotein cholesterol level, alb.

see more →